Breakthrough Treatment: How PARP Inhibitors Are Changing the Game for BRCA Gene Mutation Breast Cancer
Breast cancer is the most common type of cancer in women. About 10% of clinical cases are “BRCA gene mutation breast cancer”. In the past, there was no precise treatment plan for this type of gene mutation breast cancer. Traditionally, chemotherapy is usually used to deal with it. With the development of medical technology, in … Read more